• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUR1 的 N 端跨膜结构域通过调节通道对 PIP2 的敏感性控制 Kir6.2 的门控。

N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.

机构信息

Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

J Gen Physiol. 2011 Mar;137(3):299-314. doi: 10.1085/jgp.201010557. Epub 2011 Feb 14.

DOI:10.1085/jgp.201010557
PMID:21321069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3047609/
Abstract

Functional integrity of pancreatic adenosine triphosphate (ATP)-sensitive potassium (K(ATP)) channels depends on the interactions between the pore-forming potassium channel subunit Kir6.2 and the regulatory subunit sulfonylurea receptor 1 (SUR1). Previous studies have shown that the N-terminal transmembrane domain of SUR1 (TMD0) interacts with Kir6.2 and is sufficient to confer high intrinsic open probability (P(o)) and bursting patterns of activity observed in full-length K(ATP) channels. However, the nature of TMD0-Kir6.2 interactions that underlie gating modulation is not well understood. Using two previously described disease-causing mutations in TMD0 (R74W and E128K), we performed amino acid substitutions to study the structural roles of these residues in K(ATP) channel function in the context of full-length SUR1 as well as TMD0. Our results revealed that although R74W and E128K in full-length SUR1 both decrease surface channel expression and reduce channel sensitivity to ATP inhibition, they arrive there via distinct mechanisms. Mutation of R74 uniformly reduced TMD0 protein levels, suggesting that R74 is necessary for stability of TMD0. In contrast, E128 mutations retained TMD0 protein levels but reduced functional coupling between TMD0 and Kir6.2 in mini-K(ATP) channels formed by TMD0 and Kir6.2. Importantly, E128K full-length channels, despite having a greatly reduced P(o), exhibit little response to phosphatidylinositol 4,5-bisphosphate (PIP(2)) stimulation. This is reminiscent of Kir6.2 channel behavior in the absence of SUR1 and suggests that TMD0 controls Kir6.2 gating by modulating Kir6.2 interactions with PIP(2). Further supporting this notion, the E128W mutation in full-length channels resulted in channel inactivation that was prevented or reversed by exogenous PIP(2). These results identify a critical determinant in TMD0 that controls Kir6.2 gating by controlling channel sensitivity to PIP(2). Moreover, they uncover a novel mechanism of K(ATP) channel inactivation involving aberrant functional coupling between SUR1 and Kir6.2.

摘要

胰腺三磷酸腺苷(ATP)敏感性钾(K(ATP))通道的功能完整性取决于孔形成钾通道亚基 Kir6.2 和调节亚基磺酰脲受体 1(SUR1)之间的相互作用。先前的研究表明,SUR1 的 N 端跨膜结构域(TMD0)与 Kir6.2 相互作用,足以赋予全长 K(ATP)通道中观察到的高固有开放概率(P(o))和爆发活动模式。然而,门控调节所依赖的 TMD0-Kir6.2 相互作用的性质尚不清楚。使用先前描述的 TMD0 中的两种致病突变(R74W 和 E128K),我们进行了氨基酸取代,以研究这些残基在全长 SUR1 以及 TMD0 背景下对 K(ATP)通道功能的结构作用。我们的结果表明,尽管全长 SUR1 中的 R74W 和 E128K 均降低了表面通道表达并降低了通道对 ATP 抑制的敏感性,但它们是通过不同的机制到达那里的。R74 的突变均匀降低了 TMD0 蛋白水平,表明 R74 对于 TMD0 的稳定性是必需的。相比之下,E128 突变保留了 TMD0 蛋白水平,但在由 TMD0 和 Kir6.2 形成的 mini-K(ATP)通道中,功能性 TMD0 和 Kir6.2 之间的偶联减少。重要的是,尽管 E128K 全长通道的 P(o)大大降低,但对磷脂酰肌醇 4,5-二磷酸(PIP(2))刺激几乎没有反应。这让人联想到缺乏 SUR1 时 Kir6.2 通道的行为,并表明 TMD0 通过调节 Kir6.2 与 PIP(2)的相互作用来控制 Kir6.2 门控。进一步支持这一观点,全长通道中的 E128W 突变导致通道失活,而外源性 PIP(2)可以阻止或逆转该失活。这些结果确定了 TMD0 中的一个关键决定因素,该决定因素通过控制通道对 PIP(2)的敏感性来控制 Kir6.2 门控。此外,它们揭示了一种涉及 SUR1 和 Kir6.2 之间异常功能偶联的新型 K(ATP)通道失活机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/fc39ecb476fd/JGP_201010557_GS_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/f4d9cf45e62c/JGP_201010557_GS_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/aa4e1ce840aa/JGP_201010557_LW_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/76da83573bb1/JGP_201010557_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/5a994622fb5a/JGP_201010557_LW_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/41788b313915/JGP_201010557R_LW_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/7ed9bf2e662c/JGP_201010557_LW_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/abbb04db17d4/JGP_201010557_GS_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/1a8a8e7133c7/JGP_201010557_LW_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/fc39ecb476fd/JGP_201010557_GS_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/f4d9cf45e62c/JGP_201010557_GS_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/aa4e1ce840aa/JGP_201010557_LW_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/76da83573bb1/JGP_201010557_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/5a994622fb5a/JGP_201010557_LW_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/41788b313915/JGP_201010557R_LW_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/7ed9bf2e662c/JGP_201010557_LW_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/abbb04db17d4/JGP_201010557_GS_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/1a8a8e7133c7/JGP_201010557_LW_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6315/3047609/fc39ecb476fd/JGP_201010557_GS_Fig9.jpg

相似文献

1
N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.SUR1 的 N 端跨膜结构域通过调节通道对 PIP2 的敏感性控制 Kir6.2 的门控。
J Gen Physiol. 2011 Mar;137(3):299-314. doi: 10.1085/jgp.201010557. Epub 2011 Feb 14.
2
ATP activates ATP-sensitive potassium channels composed of mutant sulfonylurea receptor 1 and Kir6.2 with diminished PIP2 sensitivity.三磷酸腺苷激活由突变型磺酰脲受体 1 和 Kir6.2 组成的对 PIP2 敏感性降低的 ATP 敏感性钾通道。
Channels (Austin). 2011 Jul-Aug;5(4):314-9. doi: 10.4161/chan.5.4.16510. Epub 2011 Jul 1.
3
The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.磺脲类受体的N端跨膜结构域(TMD0)和胞质连接区(L0)决定了KATP通道独特的内在门控机制。
J Physiol. 2006 Oct 15;576(Pt 2):379-89. doi: 10.1113/jphysiol.2006.112748. Epub 2006 Aug 3.
4
Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.工程化 SUR1 与 Kir6.2 的相互作用增强了 KATP 通道对 ATP 的敏感性。
J Gen Physiol. 2012 Aug;140(2):175-87. doi: 10.1085/jgp.201210803. Epub 2012 Jul 16.
5
Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.通过SUR1核苷酸结合结构域1对KATP通道表达和活性的调节
Channels (Austin). 2007 Jul-Aug;1(4):315-23. doi: 10.4161/chan.5083. Epub 2007 Sep 25.
6
Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.构象性阻滞剂罗丹明123揭示ATP结合后KATP通道SUR-Kir6.2界面的重塑
J Physiol. 2007 Jul 1;582(Pt 1):27-39. doi: 10.1113/jphysiol.2007.134288. Epub 2007 May 17.
7
Impact of disease-causing SUR1 mutations on the KATP channel subunit interface probed with a rhodamine protection assay.用罗丹明保护实验探测致病变异 SUR1 对 KATP 通道亚基界面的影响。
J Biol Chem. 2010 Jan 29;285(5):3084-91. doi: 10.1074/jbc.M109.043307. Epub 2009 Nov 20.
8
Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.Mg-核苷酸与 SUR1 相互作用激活 K(ATP) 通道。
J Gen Physiol. 2010 Oct;136(4):389-405. doi: 10.1085/jgp.201010475.
9
ATP-sensitive K+ channels: regulation of bursting by the sulphonylurea receptor, PIP2 and regions of Kir6.2.ATP敏感性钾通道:磺酰脲受体、磷脂酰肌醇-4,5-二磷酸(PIP2)及内向整流钾通道6.2(Kir6.2)区域对爆发式发放的调节
J Physiol. 2006 Mar 1;571(Pt 2):303-17. doi: 10.1113/jphysiol.2005.100719. Epub 2005 Dec 22.
10
Regulation of cloned ATP-sensitive K channels by phosphorylation, MgADP, and phosphatidylinositol bisphosphate (PIP(2)): a study of channel rundown and reactivation.磷酸化、MgADP和磷脂酰肌醇二磷酸(PIP(2))对克隆的ATP敏感性钾通道的调节:通道耗竭与重新激活的研究
J Gen Physiol. 2000 Sep;116(3):391-410. doi: 10.1085/jgp.116.3.391.

引用本文的文献

1
Structure of an open K channel reveals tandem PIP binding sites mediating the Kir6.2 and SUR1 regulatory interface.开放钾通道结构揭示串联 PIP 结合位点介导 Kir6.2 和 SUR1 调节界面。
Nat Commun. 2024 Mar 20;15(1):2502. doi: 10.1038/s41467-024-46751-5.
2
Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K Channel.配体介导电哺乳动物胰腺 K 通道的结构动力学。
J Mol Biol. 2022 Oct 15;434(19):167789. doi: 10.1016/j.jmb.2022.167789. Epub 2022 Aug 11.
3
Simulating PIP-Induced Gating Transitions in Kir6.2 Channels.模拟PIP诱导的Kir6.2通道门控转变

本文引用的文献

1
Domain reorientation and rotation of an intracellular assembly regulate conduction in Kir potassium channels.域重定向和细胞内组装的旋转调节 Kir 钾通道的传导。
Cell. 2010 Jun 11;141(6):1018-29. doi: 10.1016/j.cell.2010.05.003.
2
PIP(2)-binding site in Kir channels: definition by multiscale biomolecular simulations.Kir通道中的磷脂酰肌醇-4,5-二磷酸(PIP(2))结合位点:通过多尺度生物分子模拟进行定义
Biochemistry. 2009 Nov 24;48(46):10926-33. doi: 10.1021/bi9013193.
3
TOPCONS: consensus prediction of membrane protein topology.TOPCONS:膜蛋白拓扑结构的一致性预测
Front Mol Biosci. 2021 Aug 10;8:711975. doi: 10.3389/fmolb.2021.711975. eCollection 2021.
4
Production and purification of ATP-sensitive potassium channel particles for cryo-electron microscopy.ATP 敏感性钾通道颗粒的生产和纯化用于冷冻电子显微镜。
Methods Enzymol. 2021;653:121-150. doi: 10.1016/bs.mie.2021.02.008. Epub 2021 Mar 22.
5
Mapping of CaM, S100A1 and PIP2-Binding Epitopes in the Intracellular N- and C-Termini of TRPM4.TRPM4 细胞内 N 端和 C 端钙调蛋白、S100A1 和 PIP2 结合表位的作图。
Int J Mol Sci. 2020 Jun 17;21(12):4323. doi: 10.3390/ijms21124323.
6
Insulin Release Mechanism Modulated by Toxins Isolated from Animal Venoms: From Basic Research to Drug Development Prospects.动物毒液中分离的毒素调节胰岛素释放机制:从基础研究到药物开发前景。
Molecules. 2019 May 14;24(10):1846. doi: 10.3390/molecules24101846.
7
Cryo-electron microscopy structures and progress toward a dynamic understanding of K channels.冷冻电子显微镜结构和对 K 通道动态理解的进展。
J Gen Physiol. 2018 May 7;150(5):653-669. doi: 10.1085/jgp.201711978. Epub 2018 Apr 23.
8
Lipid signaling to membrane proteins: From second messengers to membrane domains and adapter-free endocytosis.脂质信号转导至膜蛋白:从第二信使到膜域和无衔接蛋白内吞作用。
J Gen Physiol. 2018 Feb 5;150(2):211-224. doi: 10.1085/jgp.201711875. Epub 2018 Jan 11.
9
Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum.核苷酸结合域二聚体的稳定化挽救了与弹性假黄瘤相关的ABCC6突变体。
J Biol Chem. 2017 Feb 3;292(5):1559-1572. doi: 10.1074/jbc.M116.759811. Epub 2016 Dec 19.
10
Running out of time: the decline of channel activity and nucleotide activation in adenosine triphosphate-sensitive K-channels.时间紧迫:三磷酸腺苷敏感性钾通道中通道活性和核苷酸激活的下降
Philos Trans R Soc Lond B Biol Sci. 2016 Aug 5;371(1700). doi: 10.1098/rstb.2015.0426.
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W465-8. doi: 10.1093/nar/gkp363. Epub 2009 May 8.
4
Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.磺脲类受体1突变在化学伴侣暴露时导致相反的胰岛素分泌缺陷。
J Biol Chem. 2009 Mar 20;284(12):7951-9. doi: 10.1074/jbc.M807012200. Epub 2009 Jan 16.
5
Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.先天性高胰岛素血症中鉴定出的新型KCNJ11突变导致ATP敏感性钾通道活性不稳定。
J Biol Chem. 2008 Apr 4;283(14):9146-56. doi: 10.1074/jbc.M708798200. Epub 2008 Feb 4.
6
Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.通过分子建模和功能分析鉴定Kir6.2上的PIP2结合位点。
EMBO J. 2007 Aug 22;26(16):3749-59. doi: 10.1038/sj.emboj.7601809. Epub 2007 Aug 2.
7
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.导致DEND综合征的磺酰脲受体SUR1突变(F132L)的作用机制。
Hum Mol Genet. 2007 Aug 15;16(16):2011-9. doi: 10.1093/hmg/ddm149. Epub 2007 Jun 21.
8
Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.与ABCC8突变相关的先天性高胰岛素血症,这些突变导致ATP敏感性钾通道转运缺陷:鉴定与挽救
Diabetes. 2007 Sep;56(9):2339-48. doi: 10.2337/db07-0150. Epub 2007 Jun 15.
9
Phosphoinositide-mediated gating of inwardly rectifying K(+) channels.磷酸肌醇介导的内向整流钾通道门控
Pflugers Arch. 2007 Oct;455(1):83-95. doi: 10.1007/s00424-007-0276-5. Epub 2007 May 23.
10
Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex.磺脲类药物通过与通道复合物结合来纠正致病的ATP敏感性钾通道的转运缺陷。
J Biol Chem. 2006 Nov 3;281(44):33403-13. doi: 10.1074/jbc.M605195200. Epub 2006 Sep 6.